Literature DB >> 12028543

Non-expression of HLA-A*2901102 N is caused by a nucleotide exchange in the mRNA splicing site at the beginning of intron 4.

H-A Elsner1, G Bernard, B Eiz-Vesper, M de Matteis, A Bernard, Rainer Blasczyk.   

Abstract

We describe the identification of the novel human leukocyte antigen (HLA) blank allele A*2901102 N which was detected in an individual of mixed race. The serological HLA class I typing was A1; B7,44 whereas PCR-SSP indicated the presence of an additional A*29 allele. The pedigree analysis demonstrated that the new blank allele segregated with the haplotype A*29null B*07, inherited from the individual's Vietnamese father. A single G-->Tau transversion was detected at position 1 of intron 4, which is a highly conserved nucleotide position in vertebrate splice donor sites. Accordingly, it is very likely that this nucleotide exchange inhibits the splicing of intron 4, resulting in a premature stop codon further downstream. Despite this alteration, transcription into mRNA was demonstrated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12028543     DOI: 10.1034/j.1399-0039.2002.590212.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  3 in total

1.  Description of the first HLA-DRB1 null allele.

Authors:  Britta Eiz-Vesper; Rainer Blasczyk; Peter A Horn
Journal:  Immunogenetics       Date:  2007-03-24       Impact factor: 2.846

2.  Identification of 8-Digit HLA-A, -B, -C, and -DRB1 Allele and Haplotype Frequencies in Koreans Using the One Lambda AllType Next-Generation Sequencing Kit.

Authors:  Wonho Choe; Jeong-Don Chae; John Jeongseok Yang; Sang-Hyun Hwang; Sung-Eun Choi; Heung-Bum Oh
Journal:  Ann Lab Med       Date:  2021-05-01       Impact factor: 3.464

3.  Phase-defined complete sequencing of the HLA genes by next-generation sequencing.

Authors:  Kazuyoshi Hosomichi; Timothy A Jinam; Shigeki Mitsunaga; Hirofumi Nakaoka; Ituro Inoue
Journal:  BMC Genomics       Date:  2013-05-28       Impact factor: 3.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.